In the same study, no patients with previous gastrointestinal disease flared upon exposure to ICIs: however, one patient in our study with inactive IBD started prophylactic treatment with a TNF-α inhibitor upon initiation of ICIs. Here, TNF is linked to inflammatory bowel disease.